XENE logo

Xenon Pharmaceuticals Inc. (XENE)

Profile

Full Name

Xenon Pharmaceuticals Inc.

Ticker

NASDAQ: XENE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Canada

IPO

November 5, 2014

Indexes

Not included

Website

https://www.xenon-pharma.com

Employees

316

Key Details

Price

$37.51(-1.78%)

Market cap

$2.89B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$3.01(-10.26% YoY)

PE ratio

-

Next earnings date

Nov 10, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $37.51
    XENE price is $37.51

    30-Day Relative Volume

    0.72
    XENE 30-day relative volume is 0.72

    Price Performance

    Price Today change

    -1.78%
    XENE price is down -1.78% today

    Price YTD change

    -4.31%
    XENE price is down -4.31% since January 1st

    Price 1-year change

    -2.85%
    XENE price is down -2.85% year-on-year

    Price 3-year change

    -0.05%
    XENE price is down -0.05% over the past 3 years

    Price Range

    Price All-time high

    $50.99
    XENE price is currently -26.44% below its historical high of $50.99

    Price 3-year low

    $26.74
    XENE price is currently +40.28% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.89B
    XENE market capitalization is $2.89 billion

    Market cap 3-year change

    +23.77%
    XENE market capitalization is up +23.77% over the past 3 years

    Market cap All-time high

    $3.77B
    XENE market capitalization is currently -23.31% below its historical high of $3.77 billion

    Market cap sector rank

    84.47%
    XENE market capitalization is higher than 84.47% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.77%
    XENE shares outstanding is up +1.77% year-on-year

    Shares Outstanding 3-Year Change

    +23.84%
    XENE shares outstanding is up +23.84% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.97
    XENE beta is 0.97

    200-day SMA

    $35.87
    XENE price is currently +4.57% above its 200-day simple moving average

    50-day SMA

    $34.54
    XENE price is currently +8.61% above its 50-day simple moving average

    RSI

    53.64
    XENE 14-day relative strength index is 53.64

    Volume

    0.72
    XENE 30-day relative volume is 0.72

    ATR

    $1.23
    XENE average true range is $1.23

    10-day Historical Volatility

    22.78%
    XENE 10-day historical volatility is 22.78%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    XENE annual revenue is $0.00

    Revenue Analysts estimate

    $7.50M
    XENE annual revenue is currently -100.00% lower than the consensus analysts' forecast

    Revenue 1-year change

    0%
    XENE annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    XENE annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$3.01
    XENE annual earnings per share is -$3.01

    EPS Analysts estimate

    -$4.29
    XENE annual earnings per share is currently -29.92% lower than the consensus analysts' forecast

    EPS 1-year change

    -10.26%
    XENE annual earnings per share is down -10.26% year-on-year

    EPS Sector rank

    28.74%
    XENE annual earnings per share is higher than 28.74% of companies in Healthcare sector

    Profit

    Gross profit

    -$2.56M
    XENE annual gross profit is -$2.56 million

    Gross margin

    -
    XENE annual gross profit margin value is unknown

    Operating profit

    -$279.30M
    XENE annual operating income is -$279.30 million

    Operating margin

    -
    XENE annual operating profit margin value is unknown

    Net income

    -$234.33M
    XENE annual net profit is -$234.33 million

    Net margin

    -
    XENE annual net profit margin value is unknown

    Expenses

    Total expenses

    $279.30M
    XENE annual total expenses is $279.30 million

    Operating expenses

    $279.30M
    XENE annual total operating expenses is $279.30 million

    Cost of goods sold

    $2.56M
    XENE annual cost of goods sold is $2.56 million

    Selling, general & administrative expenses

    $68.90M
    XENE annual SGA is $68.90 million

    Depreciation and amortization

    $2.56M
    XENE annual depreciation & amortization is $2.56 million

    Interest expense

    $0.00
    XENE annual interest expense is $0.00

    Income tax

    -$4.09M
    XENE annual income tax is -$4.09 million

    EBIT & EBITDA

    EBIT

    -$279.30M
    XENE annual earnings before interest & taxes is -$279.30 million

    EBITDA

    -$276.74M
    XENE annual EBITDA is -$276.74 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.07B
    XENE annual total assets is $1.07 billion

    Non current assets

    $162.88M
    XENE annual long term assets is $162.88 million

    Current assets

    $635.26M
    XENE annual total current assets is $635.26 million

    Cash and cash equivalents

    $626.90M
    XENE annual cash & cash equivalents is $626.90 million

    Accounts receivable

    $1.47M
    XENE annual accounts receivable is $1.47 million

    Inventory

    $0.00
    XENE annual inventory is $0.00

    Liabilities

    Total liabilities

    $312.19M
    XENE annual total liabilities is $312.19 million

    Long term liabilities

    $268.95M
    XENE annual total long term liabilities is $268.95 million

    Current liabilities

    $35.59M
    XENE annual total current liabilities is $35.59 million

    Accounts payable

    $5.07M
    XENE annual accounts payable is $5.07 million

    Debt

    Total debt

    $9.02M
    XENE annual total debt is $9.02 million

    Total debt 1-year change

    -17.32%
    XENE annual total debt is down -17.32% year-on-year

    Long term debt

    $7.65M
    XENE annual long term debt is $7.65 million

    Short term debt

    $1.37M
    XENE annual short term debt is $1.37 million

    Equity & Capital

    Shareholders equity

    $754.90M
    XENE annual stockholders equity is $754.90 million

    Book value

    $754.90M
    XENE annual book value is $754.90 million

    Retained earnings

    -$899.47M
    XENE annual retained earnings is -$899.47 million

    Working capital

    $599.67M
    XENE annual working capital is $599.67 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$181.39M
    XENE annual cash flow from operations is -$181.39 million

    Cash from operations 1-year change

    -20.04%
    XENE annual cash flow from operations is down -20.04% year-on-year

    Cash from investing

    $165.00M
    XENE annual cash flow from investing activities is $165.00 million

    Cash from investing 1-year change

    +248.13%
    XENE annual cash flow from investing activities is up +248.13% year-on-year

    Cash from financing

    $12.13M
    XENE annual cash flow from financing activities is $12.13 million

    Cash from financing 1-year change

    -96.57%
    XENE annual cash flow from financing activities is down -96.57% year-on-year

    CAPEX

    CAPEX

    $3.08M
    XENE annual capital expenditures is $3.08 million

    CAPEX 1-year change

    -45.26%
    XENE annual capital expenditures is down -45.26% year-on-year

    Free Cash Flow

    Free cash flow

    -$184.46M
    XENE annual free cash flow is -$184.46 million

    Free cash flow 1-year change

    -17.7%
    XENE annual free cash flow is down -17.7% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    XENE annual gross profit margin value is unknown

    Operating margin

    -
    XENE annual operating profit margin value is unknown

    Net margin

    -
    XENE annual net profit margin value is unknown

    ROA & ROE

    ROA

    -23.07%
    XENE annual return on assets is -23.07%

    ROE

    -27.85%
    XENE annual return on equity is -27.85%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    XENE price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    XENE price to earnings ratio is unknown

    PB Ratio

    PB ratio

    4.56
    XENE price to book ratio is 4.56

    PB ratio Sector rank

    75.51%
    XENE price to book ratio is higher than 75.51% of companies in Healthcare sector

    PS Ratio

    PS ratio

    385.63
    XENE price to sales ratio is 385.63

    PS ratio Sector rank

    95.41%
    XENE price to sales ratio is higher than 95.41% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $2.41B
    XENE enterprise value is $2.41 billion

    Enterprise value Sector rank

    82.01%
    XENE enterprise value is higher than 82.01% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -7.65
    XENE EV/EBITDA is -7.65

    EV/EBITDA Sector rank

    16.91%
    XENE EV/EBITDA is higher than 16.91% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    17.85
    XENE annual current ratio is 17.85

    Quick ratio

    17.85
    XENE annual quick ratio is 17.85

    Leverage

    Debt to equity

    0.01
    XENE annual debt to equity ratio is 0.01

    Interest coverage ratio

    -
    XENE annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    XENE piotroski f-score value is unknown

    Altman Z-Score

    4.19
    XENE altman z-score is 4.19

    Analyst ratings

    Recent major analysts updates

    Sep 2, 25 RBC Capital
    Outperform
    Aug 12, 25 Wedbush
    Outperform
    Aug 12, 25 RBC Capital
    Outperform
    Aug 12, 25 Chardan Capital
    Buy
    May 14, 25 Evercore ISI Group
    Outperform
    May 13, 25 Wells Fargo
    Overweight
    May 13, 25 RBC Capital
    Outperform
    May 13, 25 Needham
    Buy
    May 13, 25 HC Wainwright & Co.
    Buy
    May 13, 25 Chardan Capital
    Buy

    Institutional Ownership

    Screeners with XENE included

    Growing Shares Outstanding
    Mid cap stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Canadian stocks
    Stocks above SMA 50
    Stocks below analysts price target
    • What is the ticker symbol for Xenon Pharmaceuticals Inc.?
    • Does Xenon Pharmaceuticals Inc. pay dividends?
    • What sector is Xenon Pharmaceuticals Inc. in?
    • What industry is Xenon Pharmaceuticals Inc. in?
    • What country is Xenon Pharmaceuticals Inc. based in?
    • When did Xenon Pharmaceuticals Inc. go public?
    • Is Xenon Pharmaceuticals Inc. in the S&P 500?
    • Is Xenon Pharmaceuticals Inc. in the NASDAQ 100?
    • Is Xenon Pharmaceuticals Inc. in the Dow Jones?
    • When was Xenon Pharmaceuticals Inc.'s last earnings report?
    • When does Xenon Pharmaceuticals Inc. report earnings?

    What is the ticker symbol for Xenon Pharmaceuticals Inc.?

    The ticker symbol for Xenon Pharmaceuticals Inc. is NASDAQ:XENE

    Does Xenon Pharmaceuticals Inc. pay dividends?

    No, Xenon Pharmaceuticals Inc. does not pay dividends

    What sector is Xenon Pharmaceuticals Inc. in?

    Xenon Pharmaceuticals Inc. is in the Healthcare sector

    What industry is Xenon Pharmaceuticals Inc. in?

    Xenon Pharmaceuticals Inc. is in the Biotechnology industry

    What country is Xenon Pharmaceuticals Inc. based in?

    Xenon Pharmaceuticals Inc. is headquartered in Canada

    When did Xenon Pharmaceuticals Inc. go public?

    Xenon Pharmaceuticals Inc.'s initial public offering (IPO) was on November 5, 2014

    Is Xenon Pharmaceuticals Inc. in the S&P 500?

    No, Xenon Pharmaceuticals Inc. is not included in the S&P 500 index

    Is Xenon Pharmaceuticals Inc. in the NASDAQ 100?

    No, Xenon Pharmaceuticals Inc. is not included in the NASDAQ 100 index

    Is Xenon Pharmaceuticals Inc. in the Dow Jones?

    No, Xenon Pharmaceuticals Inc. is not included in the Dow Jones index

    When was Xenon Pharmaceuticals Inc.'s last earnings report?

    Xenon Pharmaceuticals Inc.'s most recent earnings report was on August 11, 2025

    When does Xenon Pharmaceuticals Inc. report earnings?

    The next expected earnings date for Xenon Pharmaceuticals Inc. is November 10, 2025
    On this page